Results for tag: "Pigmented Lesion Drug"

The Pigmented Lesion Drug market is a subset of the Dermatological Drugs market, which focuses on the treatment of skin conditions. Pigmented Lesion Drugs are used to treat conditions such as melasma, lentigines, and post-inflammatory hyperpigmentation. These drugs are typically topical creams or ointments, and may contain active ingredients such as hydroquinone, tretinoin, and corticosteroids. Pigmented Lesion Drugs are used to reduce the appearance of dark spots on the skin, and can be used in combination with other treatments such as chemical peels and laser therapy. Some companies in the Pigmented Lesion Drug market include Galderma, Allergan, and Sun Pharmaceuticals. Galderma offers a range of topical creams and ointments, including Tri-Luma and EpiQuin Micro. Allergan produces a range of topical creams and ointments, including Lustra and Solage. Sun Pharmaceuticals offers a range of topical creams and ointments, including Melacare and Melalite. Show Less Read more